Showing results (611-620 of 2,753) with videos related to

Sort By:
Pageof 276
Neoplasia (New York, N.Y.)|October 2, 2024
Targeted immune cell therapy for hepatocellular carcinoma using expanded liver mononuclear cell-derived natural killer cellsXin Hu, Yifang Shui, Seiichi Shimizu, et al.
Neoplasia (New York, N.Y.)|October 4, 2024
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferationYingwei Huang, Qiqi Wang, Weiwei Zhou, et al.
Neoplasia (New York, N.Y.)|August 14, 2024
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancerJingjing Zhang, Ping Zhou, Tiancheng Wu, et al.
Neoplasia (New York, N.Y.)|October 22, 2024
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumorLe Hien Giang, Kuo-Sheng Wu, Wei-Chung Lee, et al.
Neoplasia (New York, N.Y.)|August 11, 2024
Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapyHanna Elisabeth Schneider, Lisa-Maria Schmitt, Albert Job, et al.
Neoplasia (New York, N.Y.)|May 24, 2025
Escitalopram facilitates tumor growth and metastasis in rodents: Is it safe?Yosi Azan, Adam Margalit, Gal Wiener, et al.
Neoplasia (New York, N.Y.)|May 25, 2025
PRMT1 inhibitor MS023 suppresses RNA splicing to sensitize small cell lung cancer to DNA damaging agentsMansi K Aparnathi, Sami Ul Haq, Jonathan St-Germain, et al.
Neoplasia (New York, N.Y.)|May 23, 2025
Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1Audrey Lafargue, Hailun Wang, Sivarajan T Chettiar, et al.
Pageof 276